A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)

Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED)

NCT00482638 ·Status: COMPLETED ·Phase: PHASE2

An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)

NCT00131430 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)

NCT01614782 ·Status: TERMINATED ·Phase: PHASE1

A 35 Day Study to Investigate the Effects of GSK1521498 on Bodyweight in Obese Subjects With Over-Eating Behaviours.

NCT01195792 ·Status: COMPLETED ·Phase: PHASE2

A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity

NCT06577766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects

NCT06054698 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY3502970 in Healthy Overweight and Obese Participants

NCT05313802 ·Status: COMPLETED ·Phase: PHASE1

Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

NCT03661879 ·Status: COMPLETED ·Phase: PHASE1

3mg Liraglutide for Overweight or Obesity

NCT03885297 ·Status: COMPLETED

Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)

NCT05035095 ·Status: COMPLETED ·Phase: PHASE3

A Phase I Study to Investigate the ADME of KD101

NCT02819934 ·Status: COMPLETED ·Phase: PHASE1

Cardiovascular System in Obesity: Effect of Treatment

NCT00000506 ·Status: COMPLETED ·Phase: PHASE2

Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)

NCT01133210 ·Status: COMPLETED ·Phase: PHASE1

A Study of TG103 Injection in Overweight or Obesity

NCT05299697 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease

NCT06501326 ·Status: RECRUITING ·Phase: PHASE4

Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus

NCT07055516 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants

NCT05841238 ·Status: COMPLETED ·Phase: PHASE1

A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities

NCT05051579 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes

NCT05881837 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Omarigliptin (MK-3102) in Obese Participants and in Participants With Type 2 Diabetes (MK-3102-004)

NCT01088711 ·Status: COMPLETED ·Phase: PHASE1

A Study of LY3537031 in Overweight, Obese, and Healthy Participants

NCT06606106 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease

NCT04844918 ·Status: COMPLETED ·Phase: PHASE3

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

NCT05929079 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of MK0364 in Obese Patients (0364-014)

NCT00131391 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety Trial to Evaluate the Effect of SCH 497079 on Weight in Obese and Overweight Participants (Study P05483)(COMPLETED)

NCT00642993 ·Status: COMPLETED ·Phase: PHASE2